Notice of Cipher Pharmaceuticals Q1 2019 Conference Call


OAKVILLE, ON, May 1, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q1 2019 financial results conference call on Friday, May 10, 2019. The call will be hosted by Robert Tessarolo, President and Chief Executive Officer, and Nadine Jutlah, Interim Chief Financial Officer. The Company will issue its financial results on the morning of May 10, 2019. 



Friday, May 10, 2019


8:30 a.m. EDT

DIAL IN NUMBER:          

(416) 764-8609 or (888) 390-0605




(888) 390-0541 (playback code 384393 #)


Available until midnight (EDT) May 17, 2019


The audio webcast can be accessed at under Investor Relations or at


About Cipher Pharmaceuticals Inc.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit

SOURCE Cipher Pharmaceuticals Inc.

Company Codes: OtherOTC:CPHRF, Toronto:CPH

Back to news